Introduction
Human cytochrome P450 1A1 (CYP1A1) is an aryl hydrocarbon hydroxylase (AHH) responsible for the bioactivation of various carcinogens such as benzo[a]pyrene. 1) Genetically controlled interindividual variation of AHH activity and its inducibility has been reported in wide ethnic groups. [2] [3] [4] 
Materials and Methods
Detailed information on the subjects was described previously. 4, 5) Informed consent was obtained from every volunteer. This study was approved by the ethics committee of Hokkaido University. The sequence of the human CYP1A1 gene described in the GenBank (accession number X02612) was used as a reference. The A of ATG start codon was deˆned as ＋1. The primers used for the speciˆc ampliˆcation and the direct sequencing of all seven exons and exon-intron junctions of the Table 1 . Primers used for the speciˆc ampliˆcation and direct sequencing analysis of the human CYP1A1 gene
Primers
Primer sequence (5?-3? orientation) Location Ampliˆed exon human CYP1A1 gene are shown in Table 1 . PCR for each region of the CYP1A1 gene was conducted in a 25 mL reaction mixture containing 100 ng of genomic DNA, KOD-plus-buŠer, 1.0 mM MgSO4, 5.0z DMSO, 0.2 mM dNTPs, 5.0 pmol of each primer and 1.0 U KOD-plus-DNA polymerase. PCR conditions consisted of an initial denaturation at 949 C for 2 min, followed by 35 cycles of denaturation at 949 C for 15 s, annealing at 609 C for 30 s and extension at 689 C for 2 min except for Ile 462 Val genotyping primer (I 462 V-S and I 462 V-A, 689 C for 1 min). Sequences were determined using ABI PRISM 3100 genetic analyzer (Applied Biosystems).
Results and Discussion
During the course of genotyping for a known Ile 462 Val polymorphism of the human CYP1A1 gene in 261 Japanese individuals, we found a novel nonsynonymous SNP as follows: SNP, 030212Saito005; GENE NAME, CYP1A1; AC-CESSION NUMBER, X02612; LENGTH, 25 base; 5?-TGGACATGACCCC W GCATCTATGGGCT-3?.
The SNP was 2546CÀG in exon 7 resulting in an amino acid change of Pro 492 Arg (Fig. 1) . Four out of 261 individuals were heterozygous for the SNP, suggesting that the allele frequency was 0.8z in Japanese. Direct sequencing of the entire exons and exon-intron boundaries of the CYP1A1 gene from the four subjects revealed no genetic linkage of the SNP with known CYP1A1 polymorphisms including MspI polymorphism. Then, the SNP was registered as a new CYP1A1 allele, CYP1A1 * 11.
Additionally, we identiˆed four nonsynonymous variants of the CYP1A1 gene, although only one heterozygote was found for each variant. Identiˆed variants were 2346ä2347 ins T, 2414TÀA, 2461CÀT and 2500CÀT causing premature stop codon, Ile 448 
Asn, Arg 464
Cys and Arg 477 Trp, respectively (Fig. 2) . The allele names of these variants were CYP1A1*7, CYP1A1*8, CYP1A1*9 and CYP1A1*10, respectively. These four variants in addition to 2346ä2347 ins T generating premature stop codon, like a known Ile 462 Val, are closely located in the heme-binding region. Thus, these amino acid substitutions are expected to alter the catalytic activity of CYP1A1. 
